Global Health Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Naresh Trehan, Chairman & Managing Director and Promoter of Global Health Limited (Medanta), has submitted a declaration under Regulation 31(4) of the SEBI Takeover Regulations to the exchanges. In the filing dated April 3, 2025, he confirms that he, along with persons acting in concert, have not created any encumbrance (such as pledge or charge) directly or indirectly on the shares of the company held by them during the financial year 2024-25. This is a routine annual compliance submission required from promoters.
This is a neutral, routine compliance filing that confirms no new pledges or encumbrances were created on the promoter's holdings during the year. It does not signal any change in promoter shareholding or financial stress, and is unlikely to have any direct impact on the stock price.